News

Vesalius Biocapital wraps up third fund

Luxembourg-based Vesalius Biocapital, a life sciences venture firm, has closed its third fund at 120 million euros. The fund's investors includes the European Investment Fund. Vesalius Biocapital III targets later-stage European life science companies in drug development, medtech, diagnostics and digital health.

DTCP racks up $350 mln for second venture and growth fund

DTCP has closed its second venture and growth fund at $350 million. The fund's limited partners include Deutsche Telekom, HarbourVest Partners and Neuberger Berman. The fund will invest between $5 million and $50 million in enterprise SaaS companies.

Lumia Capital seeks second fund

Lightspeed Venture Partners raises $2.11 bln of new capital

Lightspeed Venture Partners has raised $2.11 billion of new capital, according to a filling with the SEC.

Tin Men pulls in over $20.8 mln for maiden venture fund

Singapore-based Tin Men has raised over $20.8 million for its debut venture fund, according to an SEC filing. No target was listed in the document.

Spark Capital looks to replicate its past successes with new investment in Feather

Friday Letter: Marketplaces are red hot, fundraising isn't cooling off

There is no need to worry that the tap is going to be turned off anytime soon.

Khosla Ventures raises pair of alternative investment vehicles

Khosla Ventures has raised a pair of alternative investment vehicles to accompany its 2018 sixth fund, according to filings with the SEC.

Tribe details its approach to investment data analysis

Emerging managers pocket $500 mln, big winners include Bluebird and Pillar